Can pazopanib hydrochloride cause interstitial lung disease or pneumonitis?

Yes, potentially fatal interstitial lung disease has been reported with pazopanib hydrochloride; patients should be monitored for lung symptoms, and treatment should be discontinued if interstitial lung disease or pneumonitis develops.